norvatis

Novartis has so far prevailed over rival drug maker Incyte, which also made an offer for MorphoSys.

Novartis in the lead to acquire cancer drug developer MorphoSys: sources

DRUG maker Novartis is in advanced talks to acquire MorphoSys, a developer of cancer treatments that has a market value of 1.6 billion euros (S$2.3 billion), two people familiar with the matter said o...

2024-02-05T15:40:00.000Z

Latest T-bills Treasury Bills Results & Interest News Latest SSB Singapore Savings Bonds News Latest COE Certificate of Entitlement News

Latest Johor-Singapore SEZ News Latest BTO Build To Order & Sales of Balance News Latest STI Straits Times Index News Latest SGX Dividends, Share Price News Latest Bonds Market News Latest Singapore Stocks To Buy News Latest Singapore Economy News